Results 131 to 140 of about 335,323 (145)
Some of the next articles are maybe not open access.
Ophthalmologica, 2005
<i>Purpose:</i> To investigate whether a protein kinase C (PKC) inhibitor and melatonin prevent proliferative vitreoretinopathy (PVR). <i>Methods:</i> Twentypigmented rabbits were used in this study. All rabbits except controls received an intravitreal injection of 0.15 ml (75,000 units) of platelet-rich plasma into their left ...
Hamdi, Er +3 more
openaire +2 more sources
<i>Purpose:</i> To investigate whether a protein kinase C (PKC) inhibitor and melatonin prevent proliferative vitreoretinopathy (PVR). <i>Methods:</i> Twentypigmented rabbits were used in this study. All rabbits except controls received an intravitreal injection of 0.15 ml (75,000 units) of platelet-rich plasma into their left ...
Hamdi, Er +3 more
openaire +2 more sources
Il Farmaco, 2001
The protein kinase C (PKC) is a serine/threonine kinase, consisting of different isoforms, implicated in numerous processes of signal transduction. To understand this enzyme well, different pharmacological tools were developed. To activate PKC specifically, phorbol esters were previously used but recent research has shown that these compounds are able ...
X, Siomboing +6 more
openaire +2 more sources
The protein kinase C (PKC) is a serine/threonine kinase, consisting of different isoforms, implicated in numerous processes of signal transduction. To understand this enzyme well, different pharmacological tools were developed. To activate PKC specifically, phorbol esters were previously used but recent research has shown that these compounds are able ...
X, Siomboing +6 more
openaire +2 more sources
The isoquinoline alkaloid chelerythrine is described as an inhibitor of SERCA. The ATPase inhibition presented two non-competitive components, Ki1 = 1, 2 μM and Ki2 = 26 μM.
Raphaël C Valente +2 more
exaly +2 more sources
Clinical cancer research : an official journal of the American Association for Cancer Research, 2000
Although clonogenic or divisional death is the main mechanism by which DNA-damaging agents demonstrate antitumor activity, recent data indicate that strategies specifically designed to trigger apoptosis may also prove to be useful antitumor agents. Protein kinase C (PKC) isoenzymes are involved in the regulation of cell proliferation, differentiation ...
S J, Chmura +5 more
openaire +1 more source
Although clonogenic or divisional death is the main mechanism by which DNA-damaging agents demonstrate antitumor activity, recent data indicate that strategies specifically designed to trigger apoptosis may also prove to be useful antitumor agents. Protein kinase C (PKC) isoenzymes are involved in the regulation of cell proliferation, differentiation ...
S J, Chmura +5 more
openaire +1 more source
CHELERYTHRINE CHLORIDE INDUCES RAPID PMN APOPTOSIS THROUGH ACTIVATION OF CASPASE-3
Shock, 1999J. F. Sweeney +3 more
openaire +1 more source
88 Decreasing the apoptotic threshold with chelerythrine chloride enhances radiation cures in vivo
International Journal of Radiation Oncology*Biology*Physics, 1997Steven J. Chmura +4 more
openaire +1 more source
Induction of EGR-TNF Radioinducible virus through BH3 Domain Antagonism with Chelerythrine Chloride
International Journal of Radiation Oncology*Biology*Physics, 2009L.C. Herman +8 more
openaire +1 more source
In vitro antifungal activity and possible mechanisms of action of chelerythrine
Pesticide Biochemistry and Physiology, 2020Na Zhao, Min Zhao, Xuefeng Liu
exaly

